At Innate Path we work with people on a spectrum of health ranging from those with serious mental health conditions to those seeking self transformation and deeper meaning in their lives. We find that dipping into the well of the subconscious mind using psychedelic psychotherapy can be profoundly useful for people regardless of what they are looking for. Contact with one’s true self, with one’s own innate healing intelligence, as well as the intelligence of the world around us is profoundly transformative.
The demand for psychedelic psychotherapy and clinicians that can provide this treatment is profound and will only continue to grow as more people discover what is possible through it. We are inviting you to join our community of psychedelic psychotherapy practitioners that are already providing cannabis and ketamine assisted psychedelic psychotherapy. The Innate Path Practitioner Community (IPPC) is a training, research, clinical practice development and business partnership that yields many benefits.
Innate Path has an ongoing research collaboration with Johns Hopkins School of Medicine researcher Alan Davis to validate cannabis and ketamine assisted psychotherapy for use in mental health. Our program evaluation is gathering psychometric data on every patient we see for safety and efficacy. We are dedicated to fine tuning our therapeutic interventions and publishing our findings for the benefit of clients and the field of mental health.